224 related articles for article (PubMed ID: 8483281)
1. [Hypervitaminosis D].
Morita R; Yamamoto I; Takada M; Ohnaka Y; Yuu I
Nihon Rinsho; 1993 Apr; 51(4):984-8. PubMed ID: 8483281
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Iatrogenic vitamin D toxicity in an infant--a case report and review of literature.
Ketha H; Wadams H; Lteif A; Singh RJ
J Steroid Biochem Mol Biol; 2015 Apr; 148():14-8. PubMed ID: 25636720
[TBL] [Abstract][Full Text] [Related]
4. Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.
Bell NH; Stern PH; Pantzer E; Sinha TK; DeLuca HF
J Clin Invest; 1979 Jul; 64(1):218-25. PubMed ID: 312811
[TBL] [Abstract][Full Text] [Related]
5. [Hypercalcemia in sarcoidosis].
Katakami N
Nihon Rinsho; 2002 Sep; 60(9):1778-84. PubMed ID: 12233075
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study of the effect of 1,25 dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on calcium homeostasis and bone tissue state in rats during hypokinesia].
Sergeev IN; Blazheevich NV; Kaplanskiĭ AS; Shvets VN; Belakovskiĭ MS
Vopr Med Khim; 1987; 33(1):100-7. PubMed ID: 3495067
[TBL] [Abstract][Full Text] [Related]
7. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.
Hughes MR; Baylink DJ; Jones PG; Haussler MR
J Clin Invest; 1976 Jul; 58(1):61-70. PubMed ID: 1084355
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages.
Hewison M; Kantorovich V; Liker HR; Van Herle AJ; Cohan P; Zehnder D; Adams JS
J Bone Miner Res; 2003 Mar; 18(3):579-82. PubMed ID: 12619944
[TBL] [Abstract][Full Text] [Related]
9. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D metabolite-mediated hypercalcemia.
Adams JS
Endocrinol Metab Clin North Am; 1989 Sep; 18(3):765-78. PubMed ID: 2673772
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.
Tebben PJ; Singh RJ; Kumar R
Endocr Rev; 2016 Oct; 37(5):521-547. PubMed ID: 27588937
[TBL] [Abstract][Full Text] [Related]
12. Hypercalcemia as a result of sarcoidosis with normal serum concentrations of vitamin D.
Falk S; Kratzsch J; Paschke R; Koch CA
Med Sci Monit; 2007 Nov; 13(11):CS133-136. PubMed ID: 17968303
[TBL] [Abstract][Full Text] [Related]
13. Effect of 25-hydroxyvitamin D3 on vitamin D metabolites in primary biliary cirrhosis.
Kaplan MM; Goldberg MJ; Matloff DS; Neer RM; Goodman DB
Gastroenterology; 1981 Oct; 81(4):681-5. PubMed ID: 6973499
[TBL] [Abstract][Full Text] [Related]
14. [Immune modulation by vitamin D analogs in the prevention of autoimmune diseases].
Bouillon R; Verstuyf A; Branisteanu D; Waer M; Mathieu C
Verh K Acad Geneeskd Belg; 1995; 57(5):371-85; discussion 385-7. PubMed ID: 8571669
[TBL] [Abstract][Full Text] [Related]
15. [Vitamin D poisoning; real and spurious].
Lockefeer JH
Ned Tijdschr Geneeskd; 1990 Oct; 134(40):1931-4. PubMed ID: 2234147
[TBL] [Abstract][Full Text] [Related]
16. Homologous up-regulation of vitamin D receptors is tissue specific in the rat.
Gensure RC; Antrobus SD; Fox J; Okwueze M; Talton SY; Walters MR
J Bone Miner Res; 1998 Mar; 13(3):454-63. PubMed ID: 9525346
[TBL] [Abstract][Full Text] [Related]
17. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
Haq M; Kremer R; Goltzman D; Rabbani SA
J Clin Invest; 1993 Jun; 91(6):2416-22. PubMed ID: 8514854
[TBL] [Abstract][Full Text] [Related]
18. Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats.
Karnauskas AJ; van Leeuwen JP; van den Bemd GJ; Kathpalia PP; DeLuca HF; Bushinsky DA; Favus MJ
J Bone Miner Res; 2005 Mar; 20(3):447-54. PubMed ID: 15746989
[TBL] [Abstract][Full Text] [Related]
19. Resorptive versus absorptive hypercalciuria in sarcoidosis: correlations with 25-hydroxy vitamin D3 and 1,25-dihydroxy vitamin D3 and parameters of disease activity.
Meyrier A; Valeyre D; Bouillon R; Paillard F; Battesti JP; Georges R
Q J Med; 1985 Mar; 54(215):269-81. PubMed ID: 3838815
[TBL] [Abstract][Full Text] [Related]
20. Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D.
Horwitz MJ; Tedesco MB; Sereika SM; Syed MA; Garcia-Ocaña A; Bisello A; Hollis BW; Rosen CJ; Wysolmerski JJ; Dann P; Gundberg C; Stewart AF
J Bone Miner Res; 2005 Oct; 20(10):1792-803. PubMed ID: 16160737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
